Richard W. Pascoe

Richard W. Pascoe

Former Chief Executive Officer and DirectoratZevra Therapeutics· In proxies 2022–2023

Pay in FY2023+203% from the year before · Zevra Therapeutics stock +42.7% the same year

Richard W. Pascoe was paid $4.1M in FY2023 (Dec), up 203%. Zevra Therapeutics stock rose 42.7% that year.

Pay$100 in the stock at the end of FY21 → $75
Pay is from the Summary Compensation Table of each Zevra Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zevra TherapeuticsPublic company · 4 yr
    • Former Chief Executive Officer and Director2022 – Present · 4 yrStock in role +11%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?